Our research goals

FightMND’s core priorities

We believe that in the coming years any person in this country diagnosed with MND should have the opportunity to participate in a clinical trial of investigative new drugs, or evidenced based re-purposed medications. This goal reflects the two core priorities of FightMND in regards to our research funding:

  • To help facilitate and expedite the pre-clinical development of promising new compounds in the laboratory through our translational research grants program
  • To help deliver these potential therapies to MND patients through the provision of access to clinical trials within the FightMND Clinical Trials Consortium.






Research Grants Awarded


Aus Clinical Trials Funded

trials we funded.

Along with bringing promising new compounds from overseas biotechnology and research bodies into clinical trials here in Australia, the pipeline will support Australian MND researchers, clinicians, and patients through funding development of homegrown drugs from our labs into clinical trials for Australian MND patients.

Our Key Components Include:

  • A Clinical Trials and Translational Research Advisory Committee (CTAC) comprised of world-class MND clinicians and researchers to help oversee our translational research grant processes and clinical trial roll-out
  • A commitment to help progress promising new drugs in the lab, funded from pre-clinical testing through to clinical trial stages, as identified by our expert advisory committee

  • A collaborative consortium of 10 leading clinical trial sites to fast-track patient recruitment once agents are ready to roll-out in clinical trials
  • And hopefully, an effective treatment for MND available to Australian patients within the next 5 to 10 years


MND Research Symposium

Our inaugural MND Research Symposium was held in Melbourne in March, 2018. Stay connected with us for more details regarding the next MND Research Symposium. Connect. Collaborate. Inspire.

View a re-cap of the 2018 Research Symposium

For Researchers

The Foundation has gathered leading MND researchers, neurologists, and experienced clinical trials physicians from Australia and abroad to lead our drug development program and research grant process, and to help facilitate the roll out clinical trials in Australian MND clinics.

Dr David Schultz

CTAC Member

Dr Ian Davis

CTAC Member

Prof. Jeremy Shefner

International Assessor

Prof. Michael Benatar

International Assessor

Join the fight,
donate today

Donate Now